Editorial: Paving the way for improved antiplatelet therapy.
Erik Lerkevang
EL
Grove
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D015195:Drug Design; D004351:Drug Resistance; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors